Clinical Trial Update: Efficacy and Safety of Low-dose Ticagrelor [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update on low-dose ticagrelor for coronary artery disease with completed status and results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Coronary Artery Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-09-30